Status:
RECRUITING
China Diabetes Registry by Metabolic Management Center
Lead Sponsor:
Guang Ning
Conditions:
Type 2 Diabetes Mellitus
Type1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Epidemiologic studies have revealed a tremendous increase in the prevalence of diabetes and related mortality worldwide. In order to meet all the challenges in the treatment of metabolic diseases in C...
Detailed Description
Epidemiologic studies have revealed a tremendous increase in the prevalence of diabetes and related mortality worldwide. The general population-based survey in China in 2010, using the American Diabet...
Eligibility Criteria
Inclusion
- Main
- Age ≥ 18 years old
- Diagnosis of diabetes mellitus based on self-reported history of diagnosed diabetes by clinicians or in line with the current domestic diagnostic criteria for diabetes
- Gender: males and females
- Provide written informed consent
- Satisfactory compliance
- Main
Exclusion
- Patients with significantly reduced life expectancy (less than 5 years)
- With Drug abuse
- With AIDS or syphilis or infectious diseases such as viral hepatitis or tuberculosis in active phase at enrollment
Key Trial Info
Start Date :
May 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2039
Estimated Enrollment :
1000000 Patients enrolled
Trial Details
Trial ID
NCT03811470
Start Date
May 31 2017
End Date
May 31 2039
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Metabolic Management center
Multiple Locations, China